index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications avec texte intégral

Open Access

46 %

Mots clés

AChR antibodies Myasthénie grave Thymoma Etiology Genetic associations Interféron de type I Interferon IFN Immune response DICER COX2 Germinal center Immunology and Microbiology Section Germinal centers FMR1 Ectopic germinal centers Autoimmunity Interleukine-23 Cardiomyopathy Auto-immunité Quality of life Immunotherapy Acetylcholine receptor Glucocorticoids Mass cytometry CyTOF Endogenous nucleic acids Inflammation Max Chemokines Long-term follow-up Acetylcholine receptors Adaptive immunity Lamin A/C nuclei Exercise Cytokines M3243AG Innate immunity Macrophages Immunity Animal models Antimir-150 Conduction disease Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Anticorps monoclonal Cellules th17 Immune regulation Interferon type-I Ferrites Transcriptome MG patients CXCL13-CXCR5 Human myoblasts Chemokine Early-onset myasthenia gravis Myasthenia gravis MiR-125 MiR-7 Experimental autoimmune myasthenia gravis PBMC Complete Freund's adjuvant Disease susceptibility Neuromuscular junction Interferon type I B cells MYB Chronicity Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Gd T cells Experimental mouse models Experimental autoimmune myasthenia gravis EAMG CCL21 LMNA Interferonopathy Fragile X syndromes Thymus Experimental models Autoimmune diseases Myoblasts Thymic epithelial cells Interleukin 23 BAFF Autoimmune disease Interferon-β Acides nucléiques endogènes Heart failure Gender Centres germinatifs ectopiques Genetics Th17 cells Chronic inflammation Clinical cell transplantation Maladie auto-immune Myasthenia Gravis MG Acetylcholine receptor antibodies CTCF COVID-19 CD31 Interferon de type I Il-23 Inflammatory cytokines Interferon